DDX24: A Potential Drug Target and Biomarker for S. cerevisiae CHL1-Like Helicase

Target Name: DDX24

NCBI ID: G57062

DDX24

DDX24: A Potential Drug Target and Biomarker for S. cerevisiae CHL1-Like Helicase

Saccharomyces cerevisiae (S. cerevisiae) is a widely cultivated yeast species that is known for its unique industrial applications, such as the production of lactic acid, ethanol, and citric acid. Among the various genes involved in the production of these industrial chemicals, the gene encoding the CHL1-like helicase (DDX24) has garnered significant interest due to its role in the process. This gene has been shown to be involved in the biosynthesis of a wide range of chemicals, including lactic acid, ethanol, and citric acid, and is also involved in the production of cellulose and cell wall materials.

The CHL1-like helicase is a member of the CCA-type ATP-binding motif (CAM) family, which is characterized by the presence of a characteristic C-terminal domain that is involved in the binding of ATP and other small molecules. This motif is found in various proteins that are involved in various cellular processes, including metabolism, stress response, and transport.

Expression and function of DDX24

DDX24 is a gene that is expressed in S. cerevisiae and is involved in the production of lactic acid, a key industrial chemical used in the production of food, beverages, and other consumer products. The gene is expressed in the cell wall, where it is involved in the biosynthesis of the cell wall material cellulose.

The function of DDX24 is well understood, and it is involved in the production of cellulose from the linear cellulose generated by the cell wall biosynthesis pathway. The gene is shown to be involved in the transfer of the appropriate genetic information from the cell wall to the cytoplasm in order to produce cellulose.

Drug targeting and biomarker potential

The potential use of DDX24 as a drug target or biomarker has been evaluated due to its involvement in the production of cellulose and its role in the production of lactic acid. Several studies have shown that inhibiting the activity of DDX24 can significantly reduce the production of cellulose and lactic acid.

One of the most promising strategies for targeting DDX24 is the use of small molecules that bind to the C-terminal domain of the CHL1-like helicase. Several studies have shown that inhibitors of the C-terminal domain of DDX24 can significantly reduce the production of cellulose and lactic acid in S. cerevisiae.

Another approach to targeting DDX24 is the use of RNA interference (RNAi) technology. RNAi is a technique that involves the introduction of small interfering RNA (siRNA) into cells in order to knockdown the expression of specific genes. By using RNAi to knockdown the expression of DDX24, it is possible to reduce the production of cellulose and lactic acid in S. cerevisiae.

Conclusion

In conclusion, the CHL1-like helicase (DDX24) is a gene that is involved in the production of cellulose and lactic acid in S. cerevisiae. The potential use of DDX24 as a drug target or biomarker has been evaluated due to its involvement in the production of these industrial chemicals. Several studies have shown that inhibiting the activity of DDX24 can significantly reduce the production of cellulose and lactic acid in S. cerevisiae. Further research is needed to fully understand the potential of DDX24 as a drug target or biomarker.

Protein Name: DEAD-box Helicase 24

Functions: ATP-dependent RNA helicase

The "DDX24 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DDX24 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets